Article information
Full text is only available in PDF
bibliografía
[1.]
W.P. Glezen, W.A. Keitel, L.H. Taber, P.A. Piedra, R.D. Clower, R.B. Couch.
Age distribution of patients with medically atended illnesses caused by sequencial variants of influenza A/H1N1: comparison to age specific infection rates, 1978-89.
Am J Epidemiol, 133 (1991), pp. 296-304
[2.]
A. Frank, L. Taber, C. Wells, W.P. Glezen, A. Paredes.
Patttern of shedding of mixoviruses and paramixoviruses in children.
J Infect Dis, 144 (1981), pp. 433-441
[3.]
J.M. Longini, J.S. Koopman, A.S. Monto, J.P. Fox.
Estimating household and community transmission parameters for influenza.
Am J Epidemiol, 115 (1982), pp. 736-751
[4.]
J.P. Fox, C.E. Hall, M.K. Cooney, H.M. Foy.
Influenza virus infection in Seattle families, 1975- 1979. Study design, methods and the occurrence of infections by time and age.
Am J Epidemiol, 116 (1982), pp. 212-227
[5.]
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Mmwr, 51 (2002), pp. 1-31
[6.]
Influenza.
Red book: report of the Committee on Infectious Diseases, 24th ed, pp. 307-315
[7.]
K.G. Nicholson, R. Snacken, A.M. Palache.
Influenza immunization polices in Europe and the United States.
Vaccine, 13 (1995), pp. 365-368
[8.]
Committee on Infectious Diseases 2002-2003.
Recommended childhood and adolescent immunization schedule-United States, 2003.
Pediatrics, 111 (2003), pp. 212
[9.]
Comité Asesor de Vacunas de la AEP.
Calendario vacunal de la Asociación Española de Pediatría 2003.
An Pediatr (Barc), 58 (2003), pp. 257-262
[10.]
A.M. LeVine, V. Koeningsknecht, J.M. Stark.
Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice.
J Virol Methods, 94 (2001), pp. 173-186
[11.]
A. Malhotra, L.R. Krilov.
Influenza and respiratory syncitial virus. Update on infection, management and prevention.
Pediatr Clin North Am, 47 (2000), pp. 353-372
[12.]
N. Cox, K. Subbarao.
Influenza.
Lancet, 354 (1999), pp. 1277-1282
[13.]
W.P. Glezen.
Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections.
Vaccine, 19(Suppl 1) (2000), pp. 56-58
[14.]
K.L. O'Brien, M.I. Walters, J. Sellman, P. Quinlisk, H. Regnery, B. Schwartz, et al.
Severe pneumococcal pneumonia in previosly healthy children: the role of preceding influenza infection.
Clin Infect Dis, 30 (2000), pp. 784-789
[15.]
S.B. Mossad.
Underused options for preventing and treating influenza.
Cleveland Clin J Med, 66 (1999), pp. 19-23
[16.]
W.P. Glezen, L.H. Taber, A. FranK, W.C. Gruber, P.A. Piedra.
Influenza virus infections in infants.
Pediatr Infect Dis J, 16 (1997), pp. 1065-1068
[17.]
T. Heikkinen, M. Thint, T. Chonmaitree.
Prevalence of various respiratory viruses in the middle ear during acute otitis media.
N Engl J Med, 340 (1999), pp. 260-264
[18.]
T. Heikkinen, O. Ruuskanen, M. Waris, T. Ziegler, M. Arola, P. Halonen.
Influenza vaccination in the prevention of acute otitis media in children.
Am J Dis Child, 145 (1991), pp. 445-448
[19.]
D.A. Clemments, L. Langdon, C. Bland, E. Walter.
Influenza A vaccine decreases the incidence of otitis media in 6- to 30- month- old children in day care.
Arch Pediatr Adolesc Med, 149 (1995), pp. 1113-1117
[20.]
R.B. Belshe, P.M. Mendelman, J. Treanor, J. King, W.C. Gruber, P. Piedra, et al.
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccines in children.
N Engl J Med, 338 (1998), pp. 1405-1412
[21.]
T. Hekkinen.
The role of respiratory viruses in otitis media.
Vaccine, 19 (2000), pp. 51-55
[22.]
M. Eriksson, R. Benet, A. Nilsson.
Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy.
Pediatr Allergy Immunol, 11 (2000), pp. 193-197
[23.]
K.M. Neuzil, P.F. Wright, J.r. Mitchel EF, M.R. Griffin.
The burden of influenza illness in children with asthma and other chronic medical conditions.
J Pediatr, 137 (2000), pp. 856-864
[24.]
P. Kramarz, F. De Stefano, P.M. Gargiullo, R.T. Chen, T.A. Lieu, E.l. Davis, et al.
Vaccine Safetly Datalink Team.
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr, 138 (2001), pp. 306-310
[25.]
R. Dagan, C.B. Hall.
Influenza A virus infection imitating bacterial sepsis in early infancy.
Pediatr Infect Dis, 3 (1984), pp. 218-221
[26.]
H.T. Kao, Y.C. Huang, T.Y. Lin.
Influenza A virus infection in infants.
J Microbiol Immunol Infect, 33 (2000), pp. 105-108
[27.]
T. Togashi, Y. Matsuzono, M. Narita.
Epidemiology of influenzaassociated encephalitis-encephalopaty in Hokkaido, the northernmost island of Japan.
Pediatr Int, 42 (2000), pp. 192-196
[28.]
L. Simonsen, M.J. Clarke, G.D. Williamson, D.F. Stroup, N.H. Arden, L.B. Schonberger.
The impact of influenza epidemics on mortality: introducing a severity index.
An J Public Health, 87 (1997), pp. 1944-1950
[29.]
R.G. Fisher, W.C. Gruber, K.M. Edwards, G.W. Reed, S.J. Tollefson, J.M. Thomson, et al.
Twenty years of outpatient respiratory syncitial virus infections a framework for vaccine efficacy trial.
Pediatrics, 99 (1997), pp. E7
[30.]
R.B. Couch, J.A. Kasel, W.P. Glezen, et al.
Influenza: its control in persons and populations.
J Infect Dis, 153 (1986), pp. 431-440
[31.]
W.P. Glezen, A. Paredes, L.H. Taber.
Influenza in children: relationship to other respiratory agents.
Jama, 243 (1980), pp. 1345-1349
[32.]
W.P. Glezen.
Considerations of the risk of influenza in children and indications for prophylaxis.
Rev Infect Dis, 2 (1980), pp. 408-420
[33.]
J.P. Mullooly, W.H. Barker.
Impact of type A influenza in children: a retrospective study.
Am J Public Health, 72 (1982), pp. 1008-1016
[34.]
K.M. Neuzil, B.G. Mellen, P.F. Wright, J.r. Mitchel EF, M.R. Griffin.
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.
N Engl J Med, 342 (2000), pp. 225-231
[35.]
G.F. Hayden, H. Frayha, H. Kattan, I. Mogarri.
Structured guidelines for the use of influenza vaccine among children with chronic pulmonary disorders.
Pediatr infect Dis J, 14 (1995), pp. 895-899
[36.]
H.S. Izurieta, W.W. Thompson, P. Kramarz, D.K. Shay, R.L. Davis, F. DeStefano, et al.
Influenza and the rates of hospitalization for respiratory disease among infants and young children.
N Engl J Med, 342 (2000), pp. 232-239
[37.]
N. Sugaya, K. Mitamura, M. Nirasawa, K. Takahashi.
The impact of winter epidemics of influenza and respiratory syncitial virus on paediatric admissions to an urban general hospital.
J Med Virol, 60 (2000), pp. 102-106
[38.]
A.S. Monto, F.M. Davenport, J.A. Naiper, J.r. Francis T.
Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren.
J Infect Dis, 122 (1970), pp. 16-25
[39.]
T.A. Reichert, N. Sugaya, D.S. Fedson, P. Glezen, M. Simonsen L Tashiro.
The Japanesse experience with vaccinating schoolchildren against influenza.
N Engl J Med, 344 (2001), pp. 889-896
[40.]
T. Tango, H. Santomi, H. Mori, K. Yamaoka.
Efficacy of influenza vaccination-the detection of a seeming efficacy.
Nippon Koshu Eisei, 37 (1990), pp. 967-978
[41.]
Centers for Disease Control and Prevention.
Epidemiology and prevention of vaccine-preventable diseases, 5th ed, pp. 247-264
[42.]
American Academy of Pediatrics. Recommended childhood and adolescent immunization schedule-United States, 2003. Pediatrics 2003;111:212. Disponible en: http://www.aap.org/policy/0212.html
[43.]
J.R. De Juanes, M.P. Arrazola.
pp. 47-50
[44.]
Centers for Disease Control and Prevention. Prevention and control of influenza: recommendation of the Advisory Committee on Immunization Practice (ACIP). MMWR 2002;51(RR-03). Disponible en: http://www.cdc.gov/mmwr/preview/htm
[45.]
Centers for Disease Control and Prevention. Questions and answers on influenza vaccine and Guillen-barre syndrome (GBS). Disponible en: www.cdc.gov/nip/vacsafe/vaccinesafety/hottopics/gbs.htm
[46.]
J. Reina.
pp. 51-61
[47.]
W.E. Beyer, A.M. Palache, J.C. De Jong, A.D. Osterhaus.
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
Vaccine, 20 (2002), pp. 1340-1353
[48.]
G. Alenxandrova, A. Smorodintsev.
Obtaining of an additionally attenuated vaccinating cryophilic influenza strain.
Rev Roum Inframicrobiol, 2 (1965), pp. 179-189
[49.]
L. Rudenko, A. Ramires, M. Barro.
Vaccination properties of live recombinant influenza types A and B used separately and in combination in children of 3-14 years.
Vorp Virusol, 36 (1991), pp. 474
[50.]
L. Rudenko, A. Slepushkin, A. Monto.
Efficacy of live attenuatedand inactivated influenza vaccine in schoolchildren and their unvaccinated contacts in Novgorod. Rusia.
J Infect Dis, 168 (1993), pp. 881-887
[51.]
H.F. Maasab.
Plaque formation of influenza virus at 25 oC.
Nature, 219 (1968), pp. 645-646
[52.]
H.F. Maasab, D.C. Deborde.
Development and characterization of cold-adapted viruses for use as live virus vaccines.
Vaccine, 3 (1985), pp. 355-369
[53.]
J. Ruiz Contreras.
Vacuna intranasal frente a la gripe.
Vacunas 2001, pp. 173-179
[54.]
R.B. Belshe, W.G. Gruber, P.M. Mendelman, H.B. Mehta, K. Mahmood, K. Reisinger, et al.
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent intranasal influenza virus vaccine.
J Infect Dis, 181 (2000), pp. 1133-1137
[55.]
FDA. First nasal mist flu vaccine approved. FDA News, 2003, 17 June. Disponible en: www.fda.gov/bbs/topics/NEWS/2003/NEW00913.html
[56.]
B.R. Murphy, D.L. Nelson, P.F. Wryght, E.L. Tiemey, M.A. Phelan, R.M. Chanock.
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.
Infecc Immun, 36 (1982), pp. 1102-1108
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica
